Gesynta Pharma Email Formats

Pharmaceutical Manufacturing • Stockholm, Stockholm County, Sweden • 11-20 Employees

Gesynta Pharma Email Formats

Gesynta Pharma uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@gesynta.se), used 53.8% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@gesynta.se	53.8%
{first name}.{last name}	john.doe@gesynta.se	46.2%

Key Contacts at Gesynta Pharma

Cristina Csimma

Member Board Of Directors

Patric Stenberg

Co-Founder And Ceo

Jan I. Olofsson

Senior Medical Director

Company overview

Headquarters	Wallingatan 24, Stockholm, Stockholm County 11124, SE
Phone number	+46733836670
Website	gesynta.se
NAICS	3254
SIC	283
Keywords	Endometriosis, Women'S Health, Arthritis, Chronic Pain, Inflammation, Phase Ii, Infertility, Phase 2, Anti-Inflammatory, Linc, Dysmenorrhea, Disease Modification, Hadean, Industrifonden, Inflammatory Pain, Karolinska, Non-Hormonal, Pge2, Disease-Modifying, Mpges-1, Prostaglandin
Founded	2017
Employees	11-20
Socials

About Gesynta Pharma

Gesynta Pharma's drug candidate vipoglanstat (GS-248) is in clinical phase II development for the treatment of endometriosis – a painful, chronic inflammatory disease that affects about 10 percent of women of reproductive age. Endometriosis often leads to severely reduced quality of life, and current drug treatments are inadequate for many patients. Gesynta Pharma aims to exploit the full potential of microsomal prostaglandin E synthase-1 (mPGES-1) as a pharmacological target by developing products in areas of unmet medical need where mPGES-1 inhibition provides clear benefits compared to current therapy. Gesynta Pharma’s second drug candidate to reach clinical development, GS-073, has the same mode of action as vipoglanstat. GS-073 is ready to enter clinical phase I for the treatment of chronic inflammatory pain. Gesynta Pharma bases its R&D on research from the Karolinska Institutet. Major shareholders include Industrifonden, Hadean Ventures, Linc, and a number of successful life science entrepreneurs.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Manager

C-Suite

Director

Employees by Department

Gesynta Pharma has 10 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Gesynta Pharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-08-07	6	$20,500,000
2025-02-20	5	$27,300,000

Funding Insights

$47,800,000

Total funding amount

$27,300,000

Most recent funding amount

Number of funding rounds

Gesynta Pharma Tech Stack

Discover the technologies and tools that power Gesynta Pharma's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

jQuery CDN

CDN

Umbraco

CMS

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Slick

JavaScript libraries

Open Graph

Miscellaneous

Bootstrap

UI frameworks

Microsoft ASP.NET

Web frameworks

Google Maps

Maps

Google Analytics

Analytics

cdnjs

CDN

Frequently asked questions

Gesynta Pharma is located in Stockholm, Stockholm County, SE.

You can reach Gesynta Pharma at +46733836670.

Gesynta Pharma was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Gesynta Pharma has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Gesynta Pharma has raised a total of $47,800,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.